BlackRock Investment Management’s NEOPHOTONICS CORP NPTN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$1.4M Sell
129,439
-2,323
-2% -$31K ﹤0.01% 2468
2016
Q3
$2.15M Buy
131,762
+5,257
+4% +$74K ﹤0.01% 2099
2016
Q2
$1.21M Buy
126,505
+9,240
+8% +$101K ﹤0.01% 2486
2016
Q1
$1.65M Buy
117,265
+10,496
+10% +$109K ﹤0.01% 2132
2015
Q4
$1.16M Buy
106,769
+142
+0.1% +$1.28K ﹤0.01% 2482
2015
Q3
$726K Sell
106,627
-628
-0.6% -$4.86K ﹤0.01% 2838
2015
Q2
$979K Buy
107,255
+103,768
+2,976% +$787K ﹤0.01% 2774
2015
Q1
$24K Hold
3,487
﹤0.01% 3404
2014
Q4
$12K Hold
3,487
﹤0.01% 3622
2014
Q3
$12K Buy
3,487
+9
+0.3% +$28 ﹤0.01% 3596
2014
Q2
$14K Sell
3,478
-65,613
-95% -$347K ﹤0.01% 3524
2014
Q1
$548K Buy
69,091
+988
+1% +$7.36K ﹤0.01% 2909
2013
Q4
$481K Sell
68,103
-2,353
-3% -$15.7K ﹤0.01% 2963
2013
Q3
$521K Buy
70,456
+1,088
+2% +$8.47K ﹤0.01% 2908
2013
Q2
$603K Buy
+69,368
New +$446K ﹤0.01% 2731

Other funds holding NPTN

BlackRock Investment Management's NPTN Position: Q4 2016 in Review

BlackRock Investment Management reduced its NEOPHOTONICS CORP (NPTN) stake by 1.8% in Q4 2016, selling an estimated $31K and leaving 129,439 shares worth $1.4M. The position accounts for ﹤0.01% of the portfolio, ranked #2468.

BlackRock Investment Management first reported a position in NPTN in Q2 2013 and has held it in 15 quarters since. The position peaked at $2.15M in Q3 2016. 127 funds tracked by Wall St. Rank hold NPTN as of Q4 2016.

  • BlackRock Investment Management held 129,439 shares of NEOPHOTONICS CORP worth $1.4M as of Q4 2016.
  • BlackRock Investment Management sold 2,323 NEOPHOTONICS CORP shares in Q4 2016, an estimated $31K.
  • NEOPHOTONICS CORP made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #2468 holding.
  • BlackRock Investment Management first reported a position in NEOPHOTONICS CORP in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Investment Management's NEOPHOTONICS CORP position peaked at $2.15M in Q3 2016.
  • 127 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.